Objective Polypyrimidine tract-binding protein 1 (PTBP1) promotes stability and translation of mRNAs coding for insulin secretion granule proteins and thereby plays a role in β-cells function. We studied whether common genetic variations within the PTBP1 locus influence insulin secretion, and/or proinsulin conversion. Methods We genotyped 1,502 healthy German subjects for four tagging single nucleotide polymorphisms (SNPs) within the PTBP1 locus (rs351974, rs11085226, rs736926, and rs123698) covering 100% of genetic variation with an r2≥0.8. The subjects were metabolically characterized by an oral glucose tolerance test with insulin, proinsulin, and C-peptide measurements. A subgroup of 320 subjects also underwent an IVGTT. Results PTBP1 SNP rs11085226 was nominally associated with lower insulinogenic index and lower cleared insulin response in the OGTT (p≤0.04). The other tested SNPs did not show any association with the analyzed OGTT-derived secretion parameters. In the IVGTT subgroup, SNP rs11085226 was accordingly associated with lower insulin levels within the first ten minutes following glucose injection (p = 0.0103). Furthermore, SNP rs351974 was associated with insulin levels in the IVGTT (p = 0.0108). Upon interrogation of MAGIC HOMA-B data, our rs11085226 result was replicated (MAGIC p = 0.018), but the rs351974 was not. Conclusions We conclude that common genetic variation in PTBP1 influences glucose-stimulated insulin secretion. This underlines the importance of PTBP1 for beta cell function in vivo.
References
[1]
Straub SG, Sharp GW (2002) Glucose-stimulated signaling pathways in biphasic insulin secretion. Diabetes Metab Res Rev 18: 451–463.
[2]
Doyle ME, Egan JM (2007) Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther 113: 546–593.
[3]
Hinke SA, Hellemans K, Schuit FC (2004) Plasticity of the beta cell insulin secretory competence: preparing the pancreatic beta cell for the next meal. J Physiol 558: 369–380.
[4]
Knoch KP, Bergert H, Borgonovo B, Saeger HD, Altkruger A, et al. (2004) Polypyrimidine tract-binding protein promotes insulin secretory granule biogenesis. Nat Cell Biol 6: 207–214.
Martin SK, Carroll R, Benig M, Steiner DF (1994) Regulation by glucose of the biosynthesis of PC2, PC3 and proinsulin in (ob/ob) mouse islets of Langerhans. FEBS Lett 356: 279–282.
[7]
Goodge KA, Hutton JC (2000) Translational regulation of proinsulin biosynthesis and proinsulin conversion in the pancreatic beta-cell. Semin Cell Dev Biol 11: 235–242.
[8]
Guest PC, Rhodes CJ, Hutton JC (1989) Regulation of the biosynthesis of insulin-secretory-granule proteins. Co-ordinate translational control is exerted on some, but not all, granule matrix constituents. Biochem J 257: 431–437.
[9]
Ort T, Voronov S, Guo J, Zawalich K, Froehner SC, et al. (2001) Dephosphorylation of beta2-syntrophin and Ca2+/mu-calpain-mediated cleavage of ICA512 upon stimulation of insulin secretion. EMBO J 20: 4013–4023.
[10]
Itoh N, Okamoto H (1980) Translational control of proinsulin synthesis by glucose. Nature 283: 100–102.
[11]
Steiner DF (1977) The Banting Memorial Lecture 1976. Insulin today. Diabetes 26: 322–340.
[12]
Alarcon C, Wicksteed B, Rhodes CJ (2006) Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level. Diabetologia 49: 2920–2929.
[13]
Knoch KP, Meisterfeld R, Kersting S, Bergert H, Altkruger A, et al. (2006) cAMP-dependent phosphorylation of PTB1 promotes the expression of insulin secretory granule proteins in beta cells. Cell Metab 3: 123–134.
[14]
Sawicka K, Bushell M, Spriggs KA, Willis AE (2008) Polypyrimidine-tract-binding protein: a multifunctional RNA-binding protein. Biochem Soc Trans 36: 641–647.
[15]
Auweter SD, Allain FH (2008) Structure-function relationships of the polypyrimidine tract binding protein. Cell Mol Life Sci 65: 516–527.
[16]
Suss C, Czupalla C, Winter C, Pursche T, Knoch KP, et al. (2009) Rapid changes of mRNA-binding protein levels following glucose and 3-isobutyl-1-methylxanthine stimulation of insulinoma INS-1 cells. Mol Cell Proteomics 8: 393–408.
[17]
Xie J, Lee JA, Kress TL, Mowry KL, Black DL (2003) Protein kinase A phosphorylation modulates transport of the polypyrimidine tract-binding protein. Proc Natl Acad Sci U S A 100: 8776–8781.
[18]
Jang SK, Wimmer E (1990) Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes Dev 4: 1560–1572.
[19]
Song Y, Tzima E, Ochs K, Bassili G, Trusheim H, et al. (2005) Evidence for an RNA chaperone function of polypyrimidine tract-binding protein in picornavirus translation. RNA 11: 1809–1824.
[20]
Cote CA, Gautreau D, Denegre JM, Kress TL, Terry NA, et al. (1999) A Xenopus protein related to hnRNP I has a role in cytoplasmic RNA localization. Mol Cell 4: 431–437.
[21]
Ahren B (2005) Type 2 diabetes, insulin secretion and beta-cell mass. Curr Mol Med 5: 275–286.
[22]
Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46: 3–19.
[23]
Steiner DF, James DE (1992) Cellular and molecular biology of the beta cell. Diabetologia 35 Suppl 2: S41–S48.
[24]
Heni M, Haupt A, Schafer SA, Ketterer C, Thamer C, et al. (2010) Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion. BMC Med Genet 11: 86.
[25]
Stumvoll M, Fritsche A, Stefan N, Hardt E, Haring H (2001) Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction. J Clin Endocrinol Metab 86: 1235–1239.
[26]
Larsson H, Ahren B (1999) Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance. J Clin Endocrinol Metab 84: 2068–2074.
[27]
Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, et al. (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168: 1609–1616.
[28]
The International HapMap Project. Nature 426: 789–796.
[29]
Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462–1470.
[30]
Tripathy D, Wessman Y, Gullstrom M, Tuomi T, Groop L (2003) Importance of obtaining independent measures of insulin secretion and insulin sensitivity during the same test: results with the Botnia clamp. Diabetes Care 26: 1395–1401.
[31]
Stefan N, Machicao F, Staiger H, Machann J, Schick F, et al. (2005) Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 48: 2282–2291.
[32]
Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, et al. (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42: 105–116.
[33]
Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B (2004) JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32: D91–D94.
[34]
Staiger H, Machicao F, Stefan N, Tschritter O, Thamer C, et al. (2007) Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. PLoS ONE 2: e832.
[35]
Fontana L. Atlas of Genetics and Cytogenetics in Oncology and Haematology: PTBP1 (polypyrimidine tract binding protein 1). Available: http://AtlasGeneticsOncology.org/Genes/P?TBP1ID46504ch19p13.html. Accessed 2012 February 1.
[36]
Rorsman P, Renstrom E (2003) Insulin granule dynamics in pancreatic beta cells. Diabetologia 46: 1029–1045.
[37]
Ehehalt F, Knoch K, Erdmann K, Krautz C, Jager M, et al. (2010) Impaired insulin turnover in islets from type 2 diabetic patients. Islets 2: 30–36.
[38]
Halban PA (1982) Differential rates of release of newly synthesized and of stored insulin from pancreatic islets. Endocrinology 110: 1183–1188.
[39]
Grodsky GM (1999) The importance of rapid insulin secretion: revisited. Diabetes Technol Ther 1: 259–260.